EX-32.1 6 lyra-ex321_6.htm EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Lyra Therapeutics, Inc. (the “Company”) for the period ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

| (1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: March 9, 2021 |  | By: | /s/ Maria Palasis, Ph.D.
|  |  | Maria Palasis, Ph.D.
|  |  | President and Chief Executive Officer (Principal Executive Officer)